Theme · live manifest · live theme JSON
GLP-1 Long '24: GLP1 Drug Producer
7 tickers · $1.68T total market cap
Group: GLP-1 Long
The current thesis on GLP-1 drug producers in Spring 2025 is bullish, driven by the increasing adoption and market expansion of GLP-1 drugs for various indications beyond diabetes, including obesity, NASH, and potentially Alzheimer'Äôs disease. The market dynamics are supported by strong clinical trial outcomes, significant demand from patients, and the development of oral formulations. However, rising competition and potential regulatory challenges pose risks to sustained dominance for existing market leaders.
GLP-1 Long '24: GLP1 Drug Producer tracks 7 publicly listed stocks in this theme: 1801.HK, 2565.HK, 3933.HK, AMGN, LLY, NVO, ROG.SW. See the constituent table for details.
Thesis update: 2025-04-01
Constituents
Build 20260520T081747
| Company | Previous Quarter Report Date | Next Expected Report Date | Last Quarter Earnings Move % | Earnings Move % | Intra-Quarter Move % | Since Last Report % | Market cap | Weight |
|---|---|---|---|---|---|---|---|---|
Eli Lilly and CompanyLLY | 04/30/2026 (BMO) | 04/30/2026 (BMO) | 1.73% | 13.17% | -16.62% | 6.03% | $965.05B | 14.2857 |
Roche Holding AGROG.SW | 01/29/2026 (AMC) | — | -0.11% | — | -11.18% | — | $321.88B | 14.2857 |
Novo Nordisk A/SNVO | 05/06/2026 (BMO) | 05/06/2026 (BMO) | -19.92% | 2.07% | -4.92% | -3.32% | $196.78B | 14.2857 |
Amgen Inc.AMGN | 04/30/2026 (AMC) | 04/30/2026 (AMC) | 8.63% | -2.43% | -5.86% | 0.28% | $178.51B | 14.2857 |
Innovent Biologics, Inc.1801.HK | 03/26/2026 (BMO) | — | 3.41% | — | -6.26% | — | $17.72B | 14.2857 |
The United Laboratories International Holdings Limited3933.HK | 03/24/2026 (BMO) | — | 1.84% | — | -12.11% | — | $2.28B | 14.2857 |
PegBio Co Ltd2565.HK | — | — | — | — | — | — | $603.0M | 14.2857 |
| Average | -0.74% | 4.27% | -9.49% | 1.00% | $240.40B | 14.2857 | ||
| Median | 1.79% | 2.07% | -8.72% | 0.28% | $178.51B | 14.2857 | ||
| Std Dev | 9.00% | 6.56% | 4.19% | 3.85% | $316.52B | 0.0% | ||
| Min | -19.92% | -2.43% | -16.62% | -3.32% | $603.0M | 14.2857 | ||
| Max | 8.63% | 13.17% | -4.92% | 6.03% | $965.05B | 14.2857 | ||
| % Positive Tickers | 66.67% | 66.67% | 0.00% | 66.67% |
* Provisional value: before LstRpt% reaches its 2-day post-report lock window (BMO/AMC adjusted), EarningsPerf is calculated from current vs pre-report and then locks to final LstRpt%.